newsfilter
← Latest News
FDA Press Releases·

FDA Roundup: December 6, 2022

Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA issued a final guidance, Homeopathic Drug Products, describing the agency’s approach to prioritizing enforcement and regulatory actions for homeopathic products marketed in the U.S. without the required FDA approval. The FDA has developed a risk-based approach under which the Agency intends to prioritize specific categories of homeopathic drug products that potentially pose a higher risk to public health, such as those intended for populations at greater risk for adverse reactions, including those with weakened immune systems, infants and children, the elderly, and ...